|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.90 EUR | +0.65% |
|
+3.11% | -8.85% |
| 07-22 | Eckert & Ziegler: BaFin reviews 2024 financial statements over Pentixapharm spin-off | DP |
| 07-22 | Eckert & Ziegler next in BaFin's sights, shares rebound | DP |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 14.4 | 14.89 | 15.9 |
| Spread/Res. | -3.40% | -6.58% | -12.52% |
| Spread/Supp. | +4.59% | +4.59% | +4.59% |
| Support | 13.3 | 13.3 | 13.3 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- EUZ Stock
- Charts Eckert & Ziegler SE
Select your edition
All financial news and data tailored to specific country editions
